Medbox To Lobby For Compassionate Care Act And Governor Cuomo's Executive Order
WEST HOLLYWOOD, Calif., March 5, 2014 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, today announced that it has joined the medical marijuana lobbying effort to call for the passage of the "Compassionate Care Act." This legislation legalizes the possession, manufacture, use, delivery, transfer, transport or administration of medical marijuana by a certified patient or designated caregiver.
New York Governor Andrew Cuomo, in his State of the State message, announced that he will be allowing people with chronic and terminal illnesses to obtain medical marijuana through Executive Order. His plan would allow certain hospitals to distribute the drug to patients suffering from serious illnesses. The plan would use executive action, which would allow up to 20 hospitals across the state to prescribe marijuana to patients who have chronic or life threatening conditions. This proposal appears to be more research oriented and is far less extensive than most states that have legalized medical marijuana.
Medbox, Inc., supports the Governor's Executive Order in addition to the "Compassionate Care Act."
"It's important to understand that Governor Cuomo's Executive Order and the 'Compassionate Care Act' are not in competition, but in fact help the marijuana industry overall by providing medical marijuana to patients in need and studying medical marijuana to improve its effectiveness on patients long term," said Medbox CEO, Dr. Bruce Bedrick. "We are encouraged to hear that Governor Cuomo has provided a rough framework on how New York would implement a medical marijuana program through Executive Order. However, 20 states and Washington D.C., have completed the research and concluded that marijuana can be effective in treating certain illnesses, which is why we need the Compassionate Care Act. Governor Cuomo's Executive Order is also necessary as the long-term effectiveness of medical marijuana will only be achieved by research to see which strains are most effective on any particular illness. The two concepts work hand in hand."
Medbox looks forward to working with key decision makers and the various stakeholders to make both these proposals a reality.
A recent Siena College poll found that 80% of New Yorkers support medical marijuana.
"Public opinion is clear: It is time patients had access to medical marijuana," continued Dr. Bedrick. "And at the same time, we need to continue to research the medicine to understand how it can be manipulated for its maximum benefit."
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices in Arizona, Florida, and has its corporate headquarters in Los Angeles, California.
Medbox offers their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the Company offers an industry award winning medical vaporizer product.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
For more information on Medbox, please contact us at (800) 762-1452 or go online to www.medboxinc.com.
SOURCE Medbox, Inc.